Survey of in Vivo Sensitivity to Chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia

David J. FryauffU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by David J. Fryauff in
Current site
Google Scholar
PubMed
Close
,
J. Kevin BairdU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by J. Kevin Baird in
Current site
Google Scholar
PubMed
Close
,
Didi CandraikusumaU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by Didi Candraikusuma in
Current site
Google Scholar
PubMed
Close
,
Sofyan MasbarU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by Sofyan Masbar in
Current site
Google Scholar
PubMed
Close
,
Mochammad A. SutamihardjaU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by Mochammad A. Sutamihardja in
Current site
Google Scholar
PubMed
Close
,
Budi LeksanaU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by Budi Leksana in
Current site
Google Scholar
PubMed
Close
,
Sekar TutiU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by Sekar Tuti in
Current site
Google Scholar
PubMed
Close
,
Hariyani MarwotoU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by Hariyani Marwoto in
Current site
Google Scholar
PubMed
Close
,
Thomas RichieU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by Thomas Richie in
Current site
Google Scholar
PubMed
Close
, and
Ali RomzanU. S. Naval Medical Research Unit No. 2, Provincial Health Service (Nusa Tenggara Barat), National Institute for Health Research, Jakarta, Indonesia

Search for other papers by Ali Romzan in
Current site
Google Scholar
PubMed
Close
Restricted access

A malariometric survey was conducted in 14 villages of Sekotong district, in Lombok, Indonesia during October 1994. Point prevalence of malaria ranged from 0% to 15% in the surveyed villages, averaging 6% overall, and Plasmodium falciparum accounted for 63% of the infections. Forty-nine patients with uncomplicated malaria and parasite counts ranging from 40 to 10,800 asexual forms/µl were enrolled in a 28-day in vivo test of chloroquine sensitivity. All subjects received a supervised therapeutic regimen of chloroquine (25 mg base/kg over a 48-hr period) and parasitemia and symptoms were closely monitored for 28 days. Asexual parasites were eliminated within four days in the 29 P. falciparum and 20 P. vivax study patients enrolled. The cumulative incidence of therapeutic failure (recurrent symptomatic parasitemia) among P. falciparum cases at days 7, 14, and 28 was 7%, 10%, and 14% (4 of 29), respectively. However in all four cases, parasitemias recurred against chloroquine blood levels below the minimally effective concentration (MEC) of 200 ng/ml and do not confirm chloroquine resistance. All 20 P. vivax parasitemias were sensitive to chloroquine and the blood remained clear, with the exception of one case in which an asymptomatic parasitemia appeared on day 28. Parasitemias by P. falciparum and P. vivax that were observed before supervised therapy, but in the presence of whole blood chloroquine above normally suppressive MEC levels, suggest resistance to suppressive or prophylactic regimens of chloroquine.

Save